Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis (Q38616463)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis |
scientific article |
Statements
1 reference
Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis (English)
1 reference
Charles Erlichman
1 reference
Shaji Kumar
1 reference
Tait D Shanafelt
1 reference
Timothy G Call
1 reference
Neil E Kay
1 reference
Charla Secreto
1 reference
Wei Ding
1 reference
Connie E Lesnick
1 reference
Jose F Leis
1 reference
Traci R Sassoon
1 reference
Deborah A Bowen
1 reference
Michael Conte
1 reference
20 September 2013
1 reference
1 reference
164
1 reference
146-150
1 reference
Identifiers
1 reference
1 reference
1 reference